A McMaster stem cell research team has made an important early step in developing a…
View More Researchers take early step toward leukemia drug therapy
Home »
Case study details leukemia patient who shed infectious SARS-CoV-2 for at least 70 days
The majority of people infected with SARS-CoV-2 appear to actively shed infectious virus for about…
View More Case study details leukemia patient who shed infectious SARS-CoV-2 for at least 70 days
Biological ‘rosetta stone’ brings scientists closer to deciphering how the body is built
Every animal, from an ant to a human, contains in their genome pieces of DNA…
View More Biological ‘rosetta stone’ brings scientists closer to deciphering how the body is built
Medicare to cover CAR-T therapy for leukemia, lymphoma
A breakthrough gene therapy will be covered for certain types of lymphoma and leukemia, Medicare…
View More Medicare to cover CAR-T therapy for leukemia, lymphoma
New genetic interactions that may impact cancer outcomes
Living cells contain tens of thousands of genes that serve as instruction guides for making…
View More New genetic interactions that may impact cancer outcomes
Pairing targeted drugs for breast and lung cancer could overcome treatment resistance
Targeted drugs for breast and lung cancer could be used together to overcome resistance to…
View More Pairing targeted drugs for breast and lung cancer could overcome treatment resistance
A young mother with leukemia: a 28-Year-old urgently needs a stem cell donor
Blood cancer is a difficult-to-treat Form of cancer. The chances of survival are low. For…
View More A young mother with leukemia: a 28-Year-old urgently needs a stem cell donor
Immune cells fighting blood cancer visualized for the first time
When cancer escapes the immune system, our defenses are rendered powerless and are unable to…
View More Immune cells fighting blood cancer visualized for the first time
Imbrium Therapeutics Announces FDA Orphan Drug Designation for Tinostamustine for The Treatment of T-Cell Prolymphocytic Leukemia
STAMFORD, Conn. – March 28, 2019 – Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and…
View More Imbrium Therapeutics Announces FDA Orphan Drug Designation for Tinostamustine for The Treatment of T-Cell Prolymphocytic Leukemia
Breast cancer: The promises of old recipes
Of the three major subtypes of breast cancer, the «triple negative» is the most lethal:…
View More Breast cancer: The promises of old recipes